Financial and prosocial biases in favor of attractive adults have been documented in the labor market, in social transactions in everyday life, and in studies involving experimental economic games. According to the taste-based discrimination model developed by economists, attractiveness-related financial and prosocial biases are the result of preferences or prejudices similar to those displayed toward members of a particular sex, racial, ethnic, or religious group. Other explanations proposed by economists and social psychologists maintain that attractiveness is a marker of personality, intelligence, trustworthiness, professional competence, or productivity. Evolutionary psychologists have argued that attractive adults are favored because they are preferred sexual partners. Evidence that stereotypes about attractive people are causally related to financial or prosocial biases toward them is weak or nonexistent. Consistent with evolutionary explanations, biases in favor of attractive women appear to be more consistent or stronger than those in favor of attractive men, and biases are more consistently reported in interactions between opposite-sex than same-sex individuals. Evolutionary explanations also account for increased prosocial behavior in situations in which attractive individuals are simply bystanders. Finally, evolutionary explanations are consistent with the psychological, physiological, and behavioral changes that occur when individuals are exposed to potential mates, which facilitate the expression of courtship behavior and increase the probability of occurrence of mating. Therefore, multiple lines of evidence suggest that mating motives play a more important role in driving financial and prosocial biases toward attractive adults than previously recognized.

The corticotropin releasing factor (CRF) exerts its effects by acting on its receptors and on the binding protein (CRFBP), and has been implicated in alcohol use disorder (AUD). Therefore, identification of the exact contribution of each protein that mediates CRF effects is necessary to design effective therapeutic strategies for AUD. A series of in vitro/in vivo experiments across different species were performed to define the biological discrete role of CRFBP in AUD. First, to establish the CRFBP role in receptor signaling, we developed a novel chimeric cell-based assay and showed that CFRBP full length can stably be expressed on the plasma membrane. We discovered that only CRFBP(10 kD) fragment is able to potentiate CRF-intracellular Ca2+ release. We provide evidence that CRHBP gene loss increased ethanol consumption in mice. Then, we demonstrate that selective reduction of CRHBP expression in the center nucleus of the amygdala (CeA) decreases ethanol consumption in ethanol-dependent rats. CRFBP amygdalar downregulation, however, does not attenuate yohimbine-induced ethanol self-administration. This effect was associated with decreased hemodynamic brain activity in the CRFBP-downregulated CeA and increased hemodynamic activity in the caudate putamen during yohimbine administration. Finally, in alcohol-dependent patients, genetic variants related to the CRFBP(10 kD) fragment were associated with greater risk for alcoholism and anxiety, while other genetic variants were associated with reduced risk for anxiety. Taken together, our data provide evidence that CRFBP may possess both inhibitory and excitatory roles and may represent a novel pharmacological target for the treatment of AUD.

The dual hormone hypothesis posits that basal cortisol and testosterone have a joint effect on motivational and behavioral systems implicated in dominance and aggression, such that traits generally associated with high testosterone manifest more in individuals with low basal cortisol levels. Whether this hypothesis applies to behavioral systems other than dominance remains unclear. In the present study, we investigated the association between basal testosterone, basal cortisol, and empathy in a large population of MBA students. Empathy was assessed with a short version of the Davis's Interpersonal Reactivity Index and with the Reading the Mind in the Eyes Test (RMET). Higher testosterone was predictive of lower empathy scores among men and women with low basal cortisol, while this association was reversed among individuals with high cortisol levels. In other words, a high-testosterone profile was found to be predictive of both high and low empathic dispositions depending on the concomitant HPA state. The effect was limited to self-reported empathy as no association was found with the RMET. This pattern of results, which emerged when data for men and women were analyzed together, remained significant only for men when analyses were run separately for the two sexes. These results add empathy to the list of behaviors regulated by the joint action of testosterone and cortisol, as outlined by the dual hormone hypothesis.

Background Alcohol use disorders (AUDs) are a major public health problem, and the few treatment options available to those seeking treatment offer only modest success rates. There remains a need to identify novel targets for the treatment of AUDs. The neuronal nicotinic acetylcholine receptors (nAChRs) represent a potential therapeutic target in the brain, as recent human genetic studies have implicated gene variants in the α5 nAChR subunit as high risk factors for developing alcohol dependence. Methods Here, we evaluate the role of α5* nAChR for ethanol-mediated behaviors using male α5+/+ and α5−/− mice. We characterized the effect of hypnotic doses of ethanol and investigated drinking behavior using an adapted Drinking-in-the Dark (DID) paradigm that has been shown to induce high ethanol consumption in mice. Results We found the α5 subunit to be critical in mediating the sedative effects of ethanol. The α5−/− mice showed slower recovery from ethanol-induced sleep, as measured by loss of righting reflex. Additionally the α5−/− mice showed enhanced impairment to ethanol-induced ataxia. We found the initial sensitivity to ethanol and ethanol metabolism to be similar in both α5+/+ and α5−/− mice. Hence the enhanced sedation is likely due to a difference in the acute tolerance of ethanol in α5−/− mice. However the α5 subunit did not play a role in ethanol consumption for ethanol concentrations ranging from 5% to 30% using the DID paradigm. Additionally, varenicline was effective in reducing ethanol intake in α5−/− mice. Conclusion Together, our data suggest that the α5 nAChR subunit is important for the sedative effects of ethanol but does not play a role in ethanol consumption in male mice. Varenicline can be a treatment option even when there is loss of function of the α5 nAChR subunit.